Kalvista Pharmaceuticals Inc (KALV) — Net Asset Quality Index
Kalvista Pharmaceuticals Inc (KALV) has a Net Asset Quality Index of 5.0% as of October 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $339.93 Million minus total liabilities of $322.93 Million yields net assets of $17.00 Million. A higher index indicates a stronger, lower-leverage balance sheet. Explore Kalvista Pharmaceuticals Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Kalvista Pharmaceuticals Inc Net Asset Quality Index Over Time (2013–2025)
This chart shows how Kalvista Pharmaceuticals Inc's Net Asset Quality Index has evolved across 16 annual periods from 2013 to 2025. As of October 2025, the index stands at 5.0%, representing net assets of $17.00 Million against total assets of $339.93 Million USD. See Kalvista Pharmaceuticals Inc (KALV) net assets for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Kalvista Pharmaceuticals Inc (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for Kalvista Pharmaceuticals Inc from 2013 to 2025, covering 16 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Kalvista Pharmaceuticals Inc market cap and net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 38.0% | $95.39 Million | $250.77 Million | $155.38 Million | ▼ -49.7 pp |
| 2024 | 87.8% | $206.58 Million | $235.40 Million | $28.82 Million | ▼ -0.1 pp |
| 2023 | 87.9% | $161.03 Million | $183.20 Million | $22.18 Million | ▼ -2.9 pp |
| 2022 | 90.8% | $185.09 Million | $203.88 Million | $18.79 Million | ▼ -3.8 pp |
| 2021 | 94.6% | $257.19 Million | $272.01 Million | $14.82 Million | ▲ +4.0 pp |
| 2020 | 90.5% | $83.75 Million | $92.53 Million | $8.78 Million | ▲ +8.6 pp |
| 2019 | 81.9% | $96.74 Million | $118.13 Million | $21.39 Million | ▲ +37.5 pp |
| 2018 | 44.4% | $27.25 Million | $61.39 Million | $34.14 Million | ▼ -46.8 pp |
| 2017 | 91.2% | $31.33 Million | $34.34 Million | $3.02 Million | ▲ +4.3 pp |
| 2016 | 86.9% | $21.50 Million | $24.75 Million | $3.25 Million | ▲ +0.2 pp |
| 2016 | 86.7% | $43.07 Million | $49.67 Million | $6.60 Million | ▼ -0.1 pp |
| 2015 | 86.8% | $49.31 Million | $56.79 Million | $7.48 Million | ▲ +751.8 pp |
| 2015 | -665.0% | $-44.18 Million | $6.64 Million | $50.83 Million | ▼ -595.4 pp |
| 2014 | -69.6% | $-4.62 Million | $6.64 Million | $11.27 Million | ▲ +264.0 pp |
| 2014 | -333.6% | $-33.71 Million | $10.11 Million | $43.81 Million | ▼ -1.9 pp |
| 2013 | -331.6% | $-28.29 Million | $8.53 Million | $36.81 Million | — |